Line 38: Line 38:  
during the coagulation process and thus cannot
 
during the coagulation process and thus cannot
 
actively participate in fibrin formation.
 
actively participate in fibrin formation.
 +
 +
 +
Warfarin and similar compounds interfere with the regeneration of vitamin K from an intermediate formed during the action
 +
of vitamin K as an essential co-factor in the production of several of the factors involved in the clotting cascade. This is by competitive
 +
inhibition of the enzyme involved in the regenerative process and leads to a reduction in available vitamin K, thereby resulting
 +
in defective blood clotting. Vitamin K dependent clotting factors are VII, IX, 11 and X so the intrinsic pathway (activated by blood
 +
vessel injury), the extrinsic pathway (activated by tissue injury) and the final common pathway (with conversion of prothrombin
 +
to thrombin, formation of fibrin and stabilisation of the platelets) is affected. However, the primary haemostatic response (formation
 +
of platelet plug) is unaffected.
 +
Increased blood vessel fragility also appears to be a result of coumarin toxicity and may account for bleeding at sites that are
 +
not subject to external trauma.
 +
Following absorption, coumarins are carried bound to plasma albumin. Therefore, effects are potentiated by drugs that are also
 +
bound to albumin such as phenylbutazone, or conditions that result in low plasma albumin levels such as renal insufficiency.
    
==Signalment==
 
==Signalment==
6,502

edits